Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Lixte Biotechnology Holdings (LIXT) Shares Outstanding (2016)

Lixte Biotechnology Holdings' Shares Outstanding history spans 7 years, with the latest figure at $47.9 million for Q3 2016.

  • For Q3 2016, Shares Outstanding changed 0.0% year-over-year to $47.9 million; the TTM value through Sep 2016 reached $47.9 million, changed 0.0%, while the annual FY2015 figure was $175000.0, N/A changed from the prior year.
  • Shares Outstanding reached $47.9 million in Q3 2016 per LIXT's latest filing, roughly flat from $47.9 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $47.9 million in Q3 2015 to a low of $35.4 million in Q1 2012.
  • Average Shares Outstanding over 5 years is $43.9 million, with a median of $43.5 million recorded in 2012.
  • Peak YoY movement for Shares Outstanding: increased 17.94% in 2012, then changed 0.0% in 2013.
  • A 5-year view of Shares Outstanding shows it stood at $41.6 million in 2012, then changed by 0.0% to $41.6 million in 2013, then grew by 9.38% to $45.5 million in 2014, then tumbled by 99.62% to $175000.0 in 2015, then soared by 27257.61% to $47.9 million in 2016.
  • Per Business Quant, the three most recent readings for LIXT's Shares Outstanding are $47.9 million (Q3 2016), $47.9 million (Q2 2016), and $47.9 million (Q1 2016).